Karin L Walker's Net Worth

$7.04 Million

Estimate Recalculated May 29, 2024 08:13PM EST

Who is Karin L Walker?

Karin L Walker has an estimated net worth of $7.04 Million. This is based on reported shares across multiple companies, which include PROTHENA CORP PUBLIC LTD CO, LifeSci Acquisition Corp., Cyclacel Pharmaceuticals, Inc., and AFFYMAX INC.

SEC CIK

Karin L Walker's CIK is 0001559422

Past Insider Trading and Trends

2023 was Karin L Walker's most active year for acquiring shares with 13 total transactions. Karin L Walker's most active month to acquire stocks was the month of January. 2023 was Karin L Walker's most active year for disposing of shares, totalling 29 transactions. Karin L Walker's most active month to dispose stocks was the month of September. 2022 saw Karin L Walker paying a total of $451,200.00 for 122,967 shares, this is the most they've acquired in one year. In 2021 Karin L Walker cashed out on 152,538 shares for a total of $1,647,395.58, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PROTHENA CORP PUBLIC LTD CO (PRTA) Snapshot price: $26.66

Chief Accounting Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 27
Form 4
—
0
$23.77
-$102,350.00
0
Jan 24
Form 4
—
0
$25.36
-$118,301.73
0
Dec 20
Form 4
—
0
$23.77
-$102,350.00
0
Nov 30
Form 4
—
0
$27.29
-$137,541.33
0
Oct 25
Form 4
—
0
$33.70
-$186,607.00
0
Sep 19
Form 4
—
0
$36.11
-$210,722.50
0
Aug 18
Form 4
—
0
$42.11
-$270,743.25
0
Jul 19
Form 4
—
0
$41.97
-$269,294.20
0
Jun 20
Form 4
—
0
$44.52
-$294,778.31
0
May 19
Form 4
—
0
$33.97
-$189,279.88
0
Apr 19
Form 4
—
0
$31.38
-$163,409.67
0
Mar 20
Form 4
—
0
$31.73
-$667,545.93
0
Scheduled
Mar 15
Form 4
—
0
—
—
0
Mar 2
Form 4
—
0
$36.06
-$420,309.30
0
Scheduled
Nov 18
Form 4
—
0
$36.14
-$843,813.03
0
Scheduled
Oct 24
Form 4
—
0
—
—
0
Feb 23
Form 4
—
0
$36.46
-$193,607.22
0
Scheduled
Nov 23
Form 4
—
0
$38.61
-$995,592.60
0
Scheduled
Oct 20
Form 4
—
0
—
—
0
Feb 25
Form 4
—
0
—
—
0
Feb 12
Form 4
—
0
—
—
0
Feb 25
Form 4
—
0
—
—
0
Feb 27
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Feb 21
Form 4
—
0
$48.91
-$63,285.00
0
Scheduled
Sep 28
Form 4
—
0
$37.32
-$275,689.48
0
Scheduled
Jul 17
Form 4
—
0
$35.01
-$172,392.05
0
Scheduled
Apr 17
Form 4
—
0
—
—
0
Feb 22
Form 4
—
0
$36.00
-$182,302.97
0
Scheduled
Oct 13
Form 4
—
0
$39.19
-$525,903.83
0
Scheduled
Sep 19
Form 4
—
0
$32.20
-$103,329.04
0
Scheduled
Apr 13
Form 4
—
0
—
—
0
Feb 24
Form 4
—
0
$35.37
-$124,735.00
0
Scheduled
Jan 13
Form 4
—
0
$38.77
-$326,036.64
0
Scheduled
Aug 12
Form 4
—
0
—
—
0
Mar 11
Form 4
—
0
$15.64
-$29,441.25
0
Scheduled
Feb 10
Form 4
—
0
$14.88
-$25,627.75
0
Scheduled
Dec 9
Form 4/A
—
0
$14.92
-$25,843.25
0
Scheduled
Oct 16
Form 4
—
0
$14.92
-$25,843.25
0
Scheduled
Oct 16
Form 4
—
0
$15.25
-$27,467.00
0
Scheduled
Aug 12
Form 4
—
0
$15.67
-$94,628.00
0
Scheduled
Jun 6
Form 4
—
0
—
—
0
Feb 4
Form 4
—
0
—
—
0
Jun 3
Form 3
—
0
—
—
0
No matching records found

LifeSci Acquisition Corp. (VINC) Snapshot price: $1.3799

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Cyclacel Pharmaceuticals, Inc. (CYCC) Snapshot price: $2.3718

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+109.47%
21.22K
—
—
40.6K
Jun 30
Form 4
+444.31%
15.82K
—
—
19.38K
Jun 14
Form 4
+100.00%
3.56K
—
—
7.12K
Jun 15
Form 4
—
0
—
—
0
Nov 9
Form 3
—
0
—
—
0
No matching records found

AFFYMAX INC No price found

VP, Finance & CAO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 2
Form 3
—
0
—
—
0
No matching records found